ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
International Stem Cell Corporation (QB)

International Stem Cell Corporation (QB) (ISCO)

0,1654
0,0054
(3,37%)
Geschlossen 13 Juli 10:00PM

International Stem Cell Corporation (QB) (ISCO) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
0,1654
( 3,37% )
Gebot
0,15
Fragen
0,20
Volumen
1.960
Durchschnittliches Volumen (3 Mio.)
US$ 5.429
Finanzvolumen
US$ 315
0,16 Tagesbereich 0,1654
0,117 52-Wochen-Bereich 0,2726
Marktkapitalisierung
Unternehmenswert
8,173M
Handelsende
0,16
Handelsbeginn
0,16
Letzte Trade
174
@
0.1654
Letzter Handelszeitpunkt
VWAP
0,160479
Erlöse (LTM)
9,29M
Nettogewinn (LTM)
-382k
Ausgegebene Aktien
8.004.389
Streubesitz (%)
46,23%
Institutioneller Besitz (%)
-
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-3,35
Kurs-Umsatz-Verhältnis (KUV)
0,14
Gewinn pro Aktie (EPS)
-0,05
Beta
-

Über International Stem Cell Corporation (QB)

International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC-hpNSC, a neural stem cell program that has completed the Phase I clinical trial for ... International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC-hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson’s disease, as well as for treating stroke, traumatic brain injury, and Alzheimer’s disease. The company offers anti-aging skin care products, including ProPlus Advanced Defense Complex, ProPlus Advanced Recovery Complex, ProPlus Eye Firming Complex, ProPlus Neck Firming Complex, ProPlus Advanced Aqueous Treatment, ProPlus Collagen Booster, ProPlus Elastin Booster, and ProPlus Brightening Toner. In addition, it provides human cell culture products comprising human skin cells and reagents for the study of skin disease, toxicology, or wound healing; human cells from the heart and blood vessels, and reagents to study cardiovascular disease and cancer; human bronchial and tracheal cell lines for the study of toxicity, cystic fibrosis, asthma, and pathogenesis; and human mammary epithelial cell lines for the study of breast cancer, three dimensional culture, and carcinogen screening. Its human cell culture products also consists of adult stem cells and reagents for regenerative medicine; human prostate cells and specialized medium to study prostate disease; human renal and bladder cells and media to study renal and bladder diseases; human corneal cells and media for the study of corneal disease; human female reproductive system cells for the study of cellular physiology; human skeletal muscle cells for the study of biology, diabetes, insulin receptor studies, muscle metabolism, muscle tissue repair, and myotube development; and other cell culture reagents and supplements for the growth, staining, and freezing of human cells. It serves professional and retail customers. The company was founded in 2001 and is headquartered in San Diego, California. Mehr anzeigen

Sektor
Health Care
Branche
-
Hauptsitz
San Diego, United States
Gegründet
2026
International Stem Cell Corporation (QB) is listed in the Health Care sector of the OTC Markets with ticker ISCO. The last closing price for International Stem Cell (QB) was US$0,16. Over the last year, International Stem Cell (QB) shares have traded in a share price range of US$ 0,117 to US$ 0,2726.

International Stem Cell (QB) currently has 8.004.389 shares in issue. The market capitalisation of International Stem Cell (QB) is US$1,32 million. International Stem Cell (QB) has a price to earnings ratio (PE ratio) of -3.35.

ISCO Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.0196-10.59459459460.1850.20.1631380.16586063CS
4-0.0046-2.705882352940.170.20.1694050.19081812CS
12-0.0173-9.469074986320.18270.21750.1456280.18579569CS
260.045437.83333333330.120.21750.1265060.16770878CS
52-0.0026-1.547619047620.1680.27260.11770290.15279395CS
1560.021514.94093120220.14390.27260.04654130.1312716CS
260-0.5596-77.18620689660.7250.750.04650770.24386939CS

ISCO - Frequently Asked Questions (FAQ)

What is the current International Stem Cell Corporation (QB) share price?
The current share price of International Stem Cell Corporation (QB) is US$ 0,1654
How many International Stem Cell Corporation (QB) shares are in issue?
International Stem Cell Corporation (QB) has 8.004.389 shares in issue
What is the market cap of International Stem Cell Corporation (QB)?
The market capitalisation of International Stem Cell Corporation (QB) is USD 1,32M
What is the 1 year trading range for International Stem Cell Corporation (QB) share price?
International Stem Cell Corporation (QB) has traded in the range of US$ 0,117 to US$ 0,2726 during the past year
What is the PE ratio of International Stem Cell Corporation (QB)?
The price to earnings ratio of International Stem Cell Corporation (QB) is -3,35
What is the cash to sales ratio of International Stem Cell Corporation (QB)?
The cash to sales ratio of International Stem Cell Corporation (QB) is 0,14
What is the registered address of International Stem Cell Corporation (QB)?
The registered address for International Stem Cell Corporation (QB) is 9745 Businesspark Avenue, San Diego, California, 92131
What is the International Stem Cell Corporation (QB) website address?
The website address for International Stem Cell Corporation (QB) is www.internationalstemcell.com

ISCO Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen